top of page
HOW WE HELP CLIENTS
From seed capital to Series A/B rounds, startup funding is the lifeline of groundbreaking innovation
Investor relations (IR) is the hidden engine behind skyrocketing stock prices and billion-dollar funding rounds.
Raising Capital
Venture capital mega-rounds is the ultimate power move for startups aiming to dominate their industry.
These off-market deals offer sky-high returns, long-term wealth-building potential.
FEATURED INSIGHTS
Private Companies
Startups like CRISPR Therapeutics and Editas Medicine are using CRISPR-Cas9 to correct genetic mutations, offering potential cures for inherited diseases like sickle cell anemia and rare blindness
Institutional Investors
CVS Health has strategically leveraged a diverse funding ecosystem to support its expansive healthcare initiatives and acquisitions.
Private Companies
Deal Value Rebound: Despite a dip in deal count, U.S. PE deal value surged by 50% compared to H1 2024, driven by larger transactions and strategic exits
Capital Catalysts: The Investors Igniting Innovation
Their true value lies not just in capital but in strategic introductions to contract manufacturers, enterprise customers, and follow-on co-investors. Tenstorrent, for example, raised over $230 million across multiple VC rounds led by Eclipse and Fidelity, leveraging that backing to refine its neural-network-optimized chip architecture and to pre-sell capacity to hyperscale data centers.
RELATED ARTICLES
> AEROSPACE & DEFENSE
> TECHNOLOGY
> LIFE SCIENCES
bottom of page